TGTX – Long Trade Setup !📈🟢
Ticker: TG Therapeutics, Inc. (NASDAQ: TGTX)
Chart: 30-Min Timeframe
Pattern: Ascending triangle breakout
🔹 Entry: $41.31 (breakout + reclaim above trend)
🔹 Stop-Loss: $39.93 (below trendline + support zone)
🔹 Take Profits:
TP1: $43.12 – Previous resistance
TP2: $45.04 – Measured move / brea
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.250 EUR
22.59 M EUR
317.81 M EUR
142.96 M
About TG Therapeutics, Inc.
Sector
Industry
CEO
Michael Sean Weiss
Website
Headquarters
Morrisville
Founded
1993
FIGI
BBG01TNWQXG1
TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.
$TGTX - 4 BreakoutsThe fourth-quarter results were well received by analysts.
There were 4 breakouts from yesterday to today:
Breakout of the 3-Month Simple Moving Average
Breakout of the Weekly Heiken Ashi Highs and Lows Average
Breakout of the 3-Month Donchian Channel High
Breakout of the Downtrend Line
We also se
TGTX (TG Therapeutics, Inc.) – 30-Min Long Trade Setup! 🚀
🔹 Asset: TGTX – NASDAQ
🔹 Timeframe: 30-Min Chart
🔹 Setup Type: Bullish Breakout (Rising Wedge & Fibonacci Retracement)
📊 Trade Plan (Long Position)
✅ Entry Zone: Above $42.50 (Breakout Confirmation)
✅ Stop-Loss (SL): Below $40.17 (Key Support Level)
🎯 Take Profit Targets
📌 TP1: $43.71 (Resistan
TG Therapeutics (TGTX) – Biotech Innovation & Global ExpansionCompany Overview:
TG Therapeutics NASDAQ:TGTX is a biotech leader focused on novel cancer and autoimmune treatments, gaining momentum as an IBD Leaderboard and IBD 50 Top 10 Growth Stock.
Key Catalysts:
Regulatory Approvals & Expansion 🌍
BRIUMVI secured approvals in Europe & the UK, unlocking n
TGTX/USD – 30-Min Long Trade Setup!📌 🚀
🔹 Asset: TGTX (TG Therapeutics, Inc.)
🔹 Timeframe: 30-Min Chart
🔹 Setup Type: Bullish Breakout Trade
📌 Trade Plan (Long Position)
✅ Entry Zone: Above $40.96 (Breakout Confirmation)
✅ Stop-Loss (SL): Below $39.25 (Invalidation Level)
🎯 Take Profit Targets:
📌 TP1: $42.86 (First Resistance Level
TGTX – 30-Min Long Trade Setup!📌 🚀📈
🔹 Asset: TG Therapeutics, Inc. (NASDAQ: TGTX)
🔹 Timeframe: 30-Min Chart
🔹 Setup Type: Bullish Breakout Trade
📌 Trade Plan (Long Position)
✅ Entry Zone: Above 38.45 (Breakout Confirmation)
✅ Stop-Loss (SL): Below 37.43 (Invalidation Level)
🎯 Take Profit Targets:
📌 TP1: 40.04 (First Resistanc
TG Therapeutics (TGTX): Biotech Advances Fuel ExpansionTG Therapeutics, Inc. (TGTX) is a biopharmaceutical company focused on developing and commercializing treatments for B-cell diseases, including cancers and autoimmune disorders. The company’s lead therapies target conditions like multiple sclerosis and leukemia, offering innovative solutions in a gr
$TGTX Stock Set For Breakout Amidst Symmetrical Triangle PatternTG Therapeutics, Inc. (NASDAQ: NASDAQ:TGTX ) a biopharmaceutical company, that focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally is set for a breakout amidst a bullish symmetrical triangle pattern
TG Therapeutics forming 3rd baseIs a company that develops and commercializes novel treatments for B-cell diseases
The stock initiated a bull trend at the end of 2023 after a breakaway gap and has gained +90% during 2024 and gave 2 opportunities to buy on breakouts
Now is forming a 3rd base and may give another opportunity to e
See all ideas
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Related stocks
Frequently Asked Questions
The current price of 1TGTX is 31.195 EUR — it has decreased by −16.09% in the past 24 hours. Watch TG THERAPEUTICS INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on MIL exchange TG THERAPEUTICS INC stocks are traded under the ticker 1TGTX.
1TGTX stock has fallen by −5.04% compared to the previous week, the month change is a −5.04% fall, over the last year TG THERAPEUTICS INC has showed a −11.73% decrease.
We've gathered analysts' opinions on TG THERAPEUTICS INC future price: according to them, 1TGTX price has a max estimate of 48.61 EUR and a min estimate of 9.72 EUR. Watch 1TGTX chart and read a more detailed TG THERAPEUTICS INC stock forecast: see what analysts think of TG THERAPEUTICS INC and suggest that you do with its stocks.
1TGTX reached its all-time high on May 2, 2025 with the price of 39.995 EUR, and its all-time low was 35.340 EUR and was reached on Apr 25, 2025. View more price dynamics on 1TGTX chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
1TGTX stock is 7.58% volatile and has beta coefficient of 0.71. Track TG THERAPEUTICS INC stock price on the chart and check out the list of the most volatile stocks — is TG THERAPEUTICS INC there?
Today TG THERAPEUTICS INC has the market capitalization of 5.26 B, it has increased by 10.45% over the last week.
Yes, you can track TG THERAPEUTICS INC financials in yearly and quarterly reports right on TradingView.
TG THERAPEUTICS INC is going to release the next earnings report on Aug 5, 2025. Keep track of upcoming events with our Earnings Calendar.
1TGTX earnings for the last quarter are 0.03 EUR per share, whereas the estimation was 0.16 EUR resulting in a −82.53% surprise. The estimated earnings for the next quarter are 0.17 EUR per share. See more details about TG THERAPEUTICS INC earnings.
TG THERAPEUTICS INC revenue for the last quarter amounts to 111.71 M EUR, despite the estimated figure of 108.96 M EUR. In the next quarter, revenue is expected to reach 120.60 M EUR.
1TGTX net income for the last quarter is 4.68 M EUR, while the quarter before that showed 22.54 M EUR of net income which accounts for −79.25% change. Track more TG THERAPEUTICS INC financial stats to get the full picture.
No, 1TGTX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 7, 2025, the company has 338 employees. See our rating of the largest employees — is TG THERAPEUTICS INC on this list?
Like other stocks, 1TGTX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade TG THERAPEUTICS INC stock right from TradingView charts — choose your broker and connect to your account.